Legal
Refine Search
Generics
Netherlands-based drugmaker Tiofarma has admitted that it took part in an agreement that resulted in significant price hikes in the UK for an essential medicine. 23 January 2020
Generics
A European Court of Justice judge has found that a deal between UK pharma major GlaxoSmithKline and generics companies can be deemed a breach of competition law. 22 January 2020
Pharmaceutical
A judge in Philadelphia, USA, has handed healthcare giant Johnson & Johnson a slight reprieve, reducing an earlier judgement of $8 billion in damages to $6.8 billion. 20 January 2020
Pharmaceutical
Swiss pharma giant Roche bilked US federal and state governments out of $1.5 billion by misrepresenting clinical studies and falsely claiming that its well-known influenza medicine Tamiflu (oseltamivir) was effective at containing potential pandemics, according to a recently unsealed whistleblower lawsuit. 14 January 2020
Pharmaceutical
The US Department of Justice (DoJ) revealed on Friday that it has obtained more than $3 billion in settlements and judgments from civil cases involving fraud and false claims against the government in the fiscal year ending September 30, 2019. 11 January 2020
Pharmaceutical
Allergan today announced that its Warner Chilcott and Watson subsidiaries have reached resolutions with all plaintiffs, including a class of direct purchasers, individual direct purchasers that previously opted out of the direct purchaser class, and a class of indirect purchasers of hormonal birth control pills Loestrin 24 Fe and Minastrin 24 Fe, concluding the previously disclosed antitrust litigation in the US District Court for the District of Rhode Island. 6 January 2020
Biotechnology
Shares in US biopharma Navidea Biopharmaceuticals closed 6% up on Monday. 31 December 2019
Pharmaceutical
Eli Lilly on Monday announced that the US District Court for the Southern District of Indiana ruled in favor of Lilly that the lung cancer drug Alimta (pemetrexed for injection) vitamin regimen patent would be infringed by a competitor that had stated its intent to market alternative salt forms of pemetrexed prior to the patent's expiration in May 2022. 31 December 2019
Biotechnology
A US jury has ordered the Gilead Sciences subsidiary Kite Pharma to pay a total of $752 million to Juno Therapeutics – which has now become part of Bristol-Myers Squibb – and the Memorial Sloan Kettering Cancer Center (MSKCC). 16 December 2019
Generics
Bankrupt generic drugmaker Rising Pharmaceuticals has made admissions over charges that it conspired to fix prices and allocate customers for an off-patent hypertension drug. 4 December 2019
Generics
Drugmakers Pfizer and Flynn Pharma might not yet be off the hook over hefty fines handed out by the UK’s competition authority that the companies claim were unlawful. 29 November 2019
Pharmaceutical
EURORDIS-Rare Diseases Europe, an alliance of over 800 rare disease patient organizations, is today urging member states of the European Union to take off the table a proposal from the Presidency of the EU Council to withdraw Article 7 of the current proposal for European cooperation on health technology assessment (HTA). 22 November 2019
Biotechnology
Continuing its battle with the Japanese pharma company, US biotech Seattle Genetics today announced that it has submitted an arbitration demand to the American Arbitration Association to resolve its dispute with Daiichi Sankyo. 13 November 2019
Biotechnology
The US Department of Health and Human Services (HHS) has filed a patent infringement lawsuit against Californian biotech major Gilead Sciences. 7 November 2019
Biotechnology
Daiichi Sankyo said today it has filed a Declaratory Judgement action in the District Court of Delaware in response to receiving communications from Seattle Genetics with respect to a collaboration between the two companies from 2008 to 2015 for the development of antibody-drug conjugates (ADCs). 5 November 2019
Pharmaceutical
Maurits Lugard and Anna-Shari Melin from law firm Sidley Austin provide an Expert View on the European Medicines Agency’s (EMA) recent guidance on medicinal product shortages and implications of this guidance. 24 October 2019
Pharmaceutical
US healthcare giant, Johnson & Johnson and its USA-based Janssen Pharmaceutical Companies confirm an agreement in principle to settle opioid litigation as publicly announced and outlined by a committee of State Attorneys General on October 21, 2019, the company revealed in a filing with the Federal Trade Commission. 24 October 2019
Pharmaceutical
Specialty pharma company Pharming Group has announced that CSL Behring has dropped charges relating to the alleged stealing of proprietary information. 24 October 2019
Pharmaceutical
Israeli drugmaker Teva Pharmaceutical Industries has announced progress in its attempts to settle cases that allege the company had a role in the US opioid crisis. 22 October 2019
Pharmaceutical
Dutch specialty pharma company Pharming Group has been named in an injunction secured in the USA by CSL Behring over the alleged stealing of proprietary information. 17 October 2019
Biotechnology
India’s Sun Pharma has been blocked in its efforts to launch its JAK inhibitor Leqselvi (deuruxolitinib) in the USA. 6 November 2024
article
The European Union's antitrust enforcer hit Israeli drugmaker Teva Pharmaceutical Industries (NYSE: TEVA) with a 463 million-euro ($502 million) fine Thursday for launching a smear campaign against a rival multiple sclerosis drug and misusing the patent system to thwart the competitor's attempt to entering the market. 31 October 2024
Biotechnology
UK pharma major GSK has sued USA-based Moderna this week, accusing the latter of violating patents protecting GSK’s COVID-19 vaccine. 16 October 2024
Generics
Two US units of Israel’s Teva Pharmaceutical Industries have agreed to pay $450 million to resolve two matters that allege Teva violated the Anti-Kickback Statute (AKS) and the False Claims Act (FCA), the US Department of Justice (DoJ) announced yesterday. 11 October 2024
Pharmaceutical
GSK has reached a settlement with 10 plaintiff firms, resolving 93% of the Zantac (ranitidine) product liability cases it faced in state courts across the USA. 10 October 2024
Pharmaceutical
Cardiopulmonary diseases specialist Liquidia Corporation closed Monday’s trading 11% higher following a favorable court ruling. 8 October 2024
Generics
Novo Nordisk has reached a settlement with Mylan Pharmaceuticals, now part of Viatris, putting an end to a US patent lawsuit over blockbuster diabetes treatment Ozempic (semaglutide). 8 October 2024
Pharmaceutical
Texas Attorney General Ken Paxton has filed a lawsuit against major pharmaceutical companies, including Eli Lilly (NYSE: LLY), alleging a conspiracy to artificially inflate the prices of insulin by up to 1,000%. 7 October 2024
Biotechnology
Bristol Myers Squibb has scored a major legal victory as a judge in New York dismissed a $6.4 billion lawsuit related to its acquisition of cancer company Celgene. 5 October 2024
Pharmaceutical
The US Department of Health and Human Services (HHS) has released final guidance for the second cycle of Medicare drug price negotiations. 3 October 2024
Pharmaceutical
Texas-based Cassava Sciences was trading 13% lower in Friday’s pre-market trading. 27 September 2024
Pharmaceutical
The Pharmaceutical Research and Manufacturers of America (PhRMA) is continuing its legal challenge against the US government’s drug pricing reforms. 24 September 2024
Pharmaceutical
On Friday, the USA’s Federal Trade Commission (FTC) brought action against the three largest prescription drug benefit managers (PBMs) - Caremark Rx, Express Scripts (ESI), and OptumRx 23 September 2024
Pharmaceutical
In a lawsuit filed in federal court in Missouri, USA, Health insurer Cigna (NYSE: CI) and its pharmacy benefit manager (PBM) Express Scripts demanded that the Federal Trade Commission (FTC) retract its July 2024 report. 18 September 2024
Generics
Several pharma companies that had moved the Delhi High Court against the government’s recent notification banning 156 fixed-dose combination (FDC) drugs have got a breather. 10 September 2024
Generics
Glenmark Pharmaceuticals has agreed to pay $25 million, based on its ability to pay, to resolve its alleged liability under the False Claims Act for conspiring to fix the price of a generic drug, the US Department of Justice announced. 5 September 2024
Generics
German pharma major Bayer has filed a lawsuit against the Russian drugmaker Promomed to protect the patent rights for Xarelto (rivaroxaban), its treatment for stroke prevention which is the best-selling drug in the Russian market at present, The Pharma Letter’s local correspondent reports. 2 September 2024
Biosimilars
Regeneron Pharmaceuticals has filed a lawsuit against Sandoz, alleging that its biosimilar to Eylea (aflibercept) infringes certain patents. 29 August 2024
Pharmaceutical
Ireland-headquartered Avadel Pharmaceuticals has updated on litigation with USA-based Jazz Pharmaceuticals. 29 August 2024
Pharmaceutical
Liquidia Corporation announced Thursday that it has filed litigation in the US District Court of the District of Columbia (Case No. 1:24-cv-02428) that challenges the recent decision by the US Food and Drug Administration (FDA) to grant three-year new clinical investigation (NCI) exclusivity to Tyvaso (treprostinil) DPI.9.6. 23 August 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze